Jason X. Cheng, M.D., Ph.D.
Assistant Professor, Department of Pathology
Dr. Cheng received an M.D. from Kunming Medical College (Kunming, China) in 1983. He completed training as a resident surgeon in the Department of Surgery, Yunnan Red Cross Hospital, Kunming, China (1983-1987) and pathology training at Beijing Medical University, receiving a Master in Pathology degree in 1990. He then served as an instructor in the Department of Pathology at Beijing Medical University from September 1990 until August 1993 when he joined the research program of Professor Rudy Juliano at the University of North Carolina (Chapel Hill) where he was awarded a Ph.D. in Pharmacology in 1997. He initiated postdoctoral training with Dr. Juliano (1997-1998) and then joined the research program of Transcriptional Regulation in Dr. Mark Ptashne’s laboratory at Memorial Sloan Kettering Cancer Center. In 2004, Dr. Cheng began residency training in Anatomic and Clinical Pathology at the University of Chicago. Following residency training, he initiated and completed subspecialty training with Dr. James Vardiman in Hematopathology, at the University of Chicago (2008-2010). Meanwhile, he also worked with Dr. Harinder Singh on PU.1 and Transcriptional Regulations of Hematopoiesis at University of Chicago.
Dr. Cheng was selected as the recipient of the Pathologist-in-Training Award from the Society of Hematopathology and received the Paul E. Strandjord Young Investigator Award from Academy of Clinical Physicians and Scientists in 2008.
Dr. Cheng is a member of the United States and Canadian Academy of Pathology, the American Society of Hematology, American Cancer Society for Research and the American Society for Clinical Pathology. He is board certified in anatomic pathology, clinical pathology and hematopathology.
Dr. Cheng joined the faculty of the Department of Pathology as Assistant Professor in April 2010.
General hematopathology, molecular biology/genetics, bone marrow diseases, myelodysplasia, acute leukemia and lymphoid disorders.
Genetic and epigenetic controls of hematopoiesis, lineage specification and leukemogenesis.